E. coli-derived human Glutaminase protein Ser17-Leu669 with N-terminal Met and 6-His tag
>80%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
N-terminal sequence Analysis
Predicted Molecular Mass
59-74 kDa, under reducing conditions
Measured by its ability to hydrolyze glutamine to glutamate. The specific activity is >12000 pmol/min/μg, as measured under the described conditions.
Recombinant Human Glutaminase His-tag Protein, CF Scientific Data Examples
Recombinant Human Glutaminase His-tag Protein Enzyme Activity
Recombinant Human Glutaminase His-tag (Catalog # 10115-GL) is measured by its ability to hydrolyze glutamine to glutamate. The activity (orange) is higher than the competitor's Glutaminase (green).
Recombinant Human Glutaminase His-tag Protein SDS-PAGE
1 μg/lane of Recombinant Human Glutaminase His-tag (Catalog # 10115-GL) and 1 μg/lane of competitor Human Glutaminase was resolved with 4-20% SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by silver staining.
Formulation, Preparation and Storage
What does CF mean?
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our
Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant
protein to be stored at a more dilute concentration.
The carrier free version does not contain BSA.
What formulation is right for me?
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or
as an ELISA standard.
In contrast, the carrier free protein is recommended for applications, in which the presence of BSA
Supplied as a 0.2 μm filtered solution in Tris, NaCl, TCEP, Glycerol and CHAPS.
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
6 months from date of receipt, -70 °C as supplied.
3 months, -70 °C under sterile conditions after opening.
Glutaminase (GLS) catalyzes the synthesis of glutamate from glutamine. There are two mammalian isozymes of glutaminase: kidney-type encoded by the GLS gene, and liver-type encoded by the GLS2 gene. The two isozymes are known to have different localization, functionality, and immunological and molecular characteristics (1, 2). The GLS gene expresses two splice variants with a conserved catalytic domain (3): kidney-type glutaminase (KGA) and a C-terminal truncated variant known as glutaminase C. Both splice variants form active tetramers and are activated by phosphate (4). The kidney glutaminase isoform, GLS, catalyzes the first reaction in the primary pathway for renal catabolism of glutamine to glutamate. It contains a mitochondrial signaling peptide, a nuclear receptor box, a catalytic glutaminase domain, three ankyrin repeats and a KEN box (5). GLS promotes respiration and ATP generation in the mitochondria by providing an alternative input to the citric acid cycle. GLS is upregulated in response to oncogenes (5-7) in several cancers (8, 9). Cancer cells with altered metabolism have been shown to depend on GLS activity and upregulated glutamine consumption (10) for growth in acute myeloid leukemina (11), breast cancer (12), colorectal cancer (13), kidney cancer (14), lung cancer (15), melanoma (16) and pancreatic cancer (17). Based on its role in cancer, GLS is a pharmaceutical target for cancer therapy (10, 12, 13, 18).
Kovacevic, Z. et al. (1983) Physiol. Rev. 63:547.
Marquez, J. et al. (2006) Neurochem. Int. 48:465.
Ramachandran, S. et al. (2016) Oncotarget. 7:57943.
Huang, Q. et al. (2018) J. Biol. Chem. 293:3535.
Thangavelu, K. et al. (2012) Proc. Natl. Acad. Sci. 109:7705.
Wise, D. et al. (2008) Proc. Natl. Adac. Sci. 105:18782.
Gao, P. et al. (2009) Nature. 458:762.
Cline, M. S. et al. (2013) Sci. Rep. 3:2652.
Cancer Genome Atlas Research Network, et al. (2013) Nat. Genet. 45:1113.
Katt, W. P. et al. (2017) Future Med. Chem. 9:223.
Willems, L. et al. (2013) Blood 122:3521.
Gross, M. I. et al. (2014) Mol. Cancer Ther. 13:890.
Huang, F. et al. (2014) Int. J. Clin. Exp. Pathol. 7:1093.
Shroff, E. H. et al. (2015) Proc. Natl. Acad. Sci. 112:6539.
van den Heuvel, A. P. et al. (2012) Cancer Biol. Ther. 13:1185.
Hernandez-Davies, J. E. et al. (2015) J. Trans. Med. 13:1.
Son, J. et al. (2013) Nature. 496:101.
Zimmermann, S.C. et al. (2018) J. Med. Chem. [Epub ahead of print].
Which Brands are Currently Available on bio‑techne.com? R&D Systems, Tocris Bioscience and ProteinSimple branded products are available to purchase through bio‑techne.com. ProteinSimple branded instruments are available to quote. ACD branded products will be available on bio‑techne.com in the near future. Novus Biologicals branded products are not currently available on bio‑techne.com and can be found at novusbio.com.
Setting the standard in quality research reagents for over 30 years
A trusted leader in quality life science reagents
Your trusted supplier for innovative and high performance life science reagents
Proprietary systems and consumables for simpler, more quantitative and affordable protein analysis
Proprietary RNAscope® technology capable of detecting and quantifying RNA biomarkers in situ at single molecule sensitivity
A world leader in developing liquid biopsy based diagnostics